Ultrasound-guided unilateral thoracic paravertebral block for postoperative analgesia in pediatric patients undergoing thoracoscopic mediastinal tumor resection: a single-center randomized controlled trial Authors: Lan Sun, Zheng Wu, Fang Wang, Zhengzheng Gao, Lijing Li, Heqi Liu, Guoliang Liu, Gan Li, Jianmin Zhang Published: 2025 ABSTRACT AbstractBackgroundThoracic paravertebral block (TPVB) has rarely been reported for pediatric mediastinal tumor surgery. This study aimed to evaluate the efficacy of unilateral TPVB for postoperative analgesia in children undergoing thoracoscopic mediastinal tumor resection, providing a potential option for multimodal analgesia in pediatric thoracic oncology surgery.MethodsChildren aged 4 to 12 years scheduled for thoracoscopic mediastinal tumor resection were enrolled and randomly assigned to either the general anesthesia group (GA group) or the general anesthesia combined with paravertebral block group (TPVB group). Postoperative pain was assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale at 2, 4, 8, 12, and 24 h after surgery. The primary outcome was the pain intensity, and secondary outcomes included pain scores at rest and during activity, postoperative opioid consumption, adverse events, and recovery quality.ResultsOf the 120 patients enrolled and randomized, 110 completed the study (GA group, n = 54; TPVB group, n = 56).Results showed that the TPVB group had significantly lower pain intensity compared to the general anesthesia group (1.8 ± 0.3 vs. 2.2 ± 0.3, p < 0.001). Pain scores at rest and during activity were significantly reduced at 2, 4, and 8 h, and pain scores at rest remained significantly lower at 12 h. Compared with the GA group, the TPVB group had lower postoperative opioid consumption (0.2 [0.1–0.3] µg/kg vs. 0.3 [0.2–0.4] µg/kg, p = 0.024), a lower incidence of desaturation in the post‑anesthesia care unit (PACU) (2 [3.6%] vs. 12 [22.2%], p = 0.003), shorter PACU stay (21 [15–27] min vs. 31 [25–35] min, p < 0.001), earlier chest tube removal (3 [3–4] days vs. 4 [3–4] days, p = 0.013), and a shorter hospital stay (5 [4–6] days vs. 6 [5–7] days, p < 0.001). There were no significant differences in adverse events between the two groups.ConclusionUnilateral TPVB for pediatric mediastinal tumor resection significantly reduces overall pain intensity within 24 h and pain scores within the first 8 h postoperatively, decreases opioid consumption during the first 24 h, and improves postoperative recovery.Trial registrationChinese Clinical Trial Registry ChiCTR2400083377, registered 23 April 2024.Keywords: Thoracic paravertebral block, Pediatric, Mediastinal tumor, Postoperative, Pain Introduction In recent years, the incidence of pediatric thoracic tumors has been increasing annually [1, 2], with mediastinal tumors being among the most common solid tumors. Pediatric mediastinal tumors are predominantly benign and often manifest with respiratory symptoms due to mass compression [3]. Video-assisted thoracoscopic surgery (VATS) has emerged as the standard approach for both the diagnosis and management of pediatric mediastinal tumors. In comparison to conventional thoracotomy, VATS offers several advantages, including reduced invasiveness, accelerated postoperative recovery, and fewer adverse events [4–8]. Nevertheless, VATS for mediastinal tumors still entails incisional and substantial local tissue trauma, causing significant acute postoperative pain. This may impede the restoration of respiratory function and heighten the risk of complications, ultimately prolonging convalescence. Single-shot or continuous thoracic epidural anesthesia (TEA) remains the gold standard for perioperative anesthesia and analgesia in thoracic surgery [9, 10]. However, the application of TEA in pediatric patients is challenging due to the ongoing development of vertebral anatomy and the softness of the ligamentum flavum in children, which diminishes the tactile “loss-of-resistance” sensation during needle insertion and demands greater technical expertise from anesthesiologists. Moreover, the limited compensatory capacity of the pediatric circulatory system renders these patients more susceptible to hypotension associated with TEA. Since 1978, ultrasound technology has been applied to regional anaesthesia [11]. Ultrasound guidance ensures both the accuracy and safety of regional anesthesia procedures. Thoracic paravertebral block (TPVB) involves the injection of local anesthetic into the paravertebral space, resulting in the blockade of multiple ipsilateral spinal nerve segments, thereby providing both somatic and sympathetic nerve coverage of the surgical area and achieving adequate analgesia [12]. Some studies have recently reported on the clinical application of TPVB in pediatric patients undergoing procedures such as pectus excavatum repair [13], thoracoscopic pulmonary surgery [14], abdominal nephrectomy [15], and cardiac surgery [16], confirming that TPVB provides satisfactory analgesia in specific pediatric surgeries. However, evidence regarding the use of TPVB in pediatric mediastinal tumor surgery remains limited. In our study, we designed a randomized controlled trial to evaluate the perioperative analgesic efficacy of a novel unilateral two-point TPVB in pediatric patients undergoing mediastinal tumor resection. By systematically assessing postoperative pain scores and complication rates, this study aimed to validate the superiority of this technique in enhancing pain management, providing robust clinical evidence for its effectiveness in reducing both postoperative pain and perioperative opioid use. Methods Study design and patient enrollment This prospective, randomized, controlled trial was conducted in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all patients and their guardians. The study was approved by the Medical Ethics Committee of Beijing Children’s Hospital, Capital Medical University ([2024]-Y-072-D). The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400083377, https://www.chictr.org.cn/showproj.html?proj=227406). We enrolled hospitalized patients aged 4 to 12 years with American Society of Anesthesiologists (ASA) physical status I–II who were scheduled to undergo thoracoscopic mediastinal tumor resection. The exclusion criteria were as follows: (1) patients requiring postoperative transfer to the intensive care unit (ICU) with indwelling tubes; (2) conversion to open thoracotomy; (3) presence of thoracic deformities; (4) history of multiple previous surgeries; (5) developmental delay or inability to communicate verbally; (6) contraindications to regional anesthesia or nerve block; and (7) known allergies to ropivacaine or other perioperative medications. Patients were also excluded if, intraoperatively, (1) severe intrathoracic adhesions were found, (2) alveolar injury occurred, or (3) the surgery lasted more than four hours. Informed consent was obtained from all participants or their legal guardians. Randomization and blinding Participants were randomly assigned in a 1:1 ratio to receive either the general anesthesia group (GA group) alone or the general anesthesia combined with paravertebral block group (TPVB group), based on computer-generated random numbers prepared by an independent third party not involved in the study. Both the anesthesia and surgical procedures were performed by designated personnel. Patients, their families, postoperative follow-up staff, and final data analysts were blinded to group allocation and the randomization process. To ensure allocation concealment, each enrolled patient was identified by a unique coded number. The randomization list was securely maintained by an independent investigator who had no role in intraoperative management or outcome assessment. The statisticians responsible for data analysis were blinded to group identity and had access only to two coded datasets, without knowledge of which corresponded to the GA or TPVB group. All statistical analyses were conducted according to the pre-specified plan using anonymized codes until data interpretation was completed. Anesthesia management All enrolled patients underwent standardized monitoring and anesthesia induction. Upon entering the operating room, patients received an electrocardiogram (ECG), pulse oximetry (SpO₂), and invasive blood pressure monitoring. Anesthesia was induced with propofol (2–3 mg/kg), sufentanil (0.3–0.5 µg/kg), and rocuronium (0.5–0.6 mg/kg). Following the attainment of adequate anesthetic depth, endotracheal intubation was performed. Anesthesia was maintained with propofol (0.1–0.2 mg/kg/min) and remifentanil (0.1–0.4 µg/kg/min). The depth of anesthesia was adjusted according to haemodynamic changes to maintain blood pressure and heart rate within 20% of baseline values. Intraoperative fluid management and use of vasoactive agents were determined by blood loss. Anesthetic depth was monitored using the bispectral index, maintained between 50 and 60 throughout the procedure. At the end of surgery, propofol and remifentanil infusions were discontinued, and sugammadex was administered five minutes later to reverse neuromuscular blockade. Extubation was performed once spontaneous breathing resumed and SpO₂ was > 90% for five minutes without supplemental oxygen. Patients were then transferred to the post-anesthesia care unit (PACU) for observation. Transfer to the general ward occurred when the Steward recovery score reached ≥ 5, and both the anesthetist and surgeon had evaluated the patient’s condition. Thoracic paravertebral block In the TPVB group, after tracheal intubation, unilateral two-point TPVB on the operative side was performed under ultrasound guidance by experienced members of a designated team. The puncture sites were chosen at the T3–4 and T6–7 levels to ensure adequate analgesia. A linear high-frequency ultrasound probe was used for localization, and a 5-cm, 21-gauge nerve block needle was inserted in-plane into the paravertebral space at the target levels. Upon entry into the space, a local anesthetic was injected, which could be visualized as spreading locally and displacing the pleura medially toward the thoracic cavity (Fig. 1). At each site, 0.5 ml/kg of 0.2–0.3% ropivacaine was administered, with a maximum total volume not exceeding 20 ml. A Ultrasound-guided paravertebral block. B Visualization of needle insertion under ultrasound guidance. C The deposition of drugs in the paravertebral space In the GA group, no regional block was performed. However, to maintain blinding, mock procedures were conducted at the T3–4 and T6–7 levels, where adhesive dressings were applied in the same manner as in the TPVB group. This approach prevented the patients and their guardians from discerning group allocation and also ensured blinding of the postoperative follow-up staff, thereby minimizing potential bias during pain assessment. Standard postoperative pain treatment and rescue analgesia Postoperative pain evaluation and rescue analgesia were performed by blinded research assistants trained in pediatric pain management. All participants received multimodal analgesia, including a patient-controlled analgesia (PCA) pump with sufentanil, single bolus doses of fentanyl, and intravenous ibuprofen when not contraindicated. Acetaminophen was excluded as it is unavailable for inpatient use at our institution. Pain scores were assessed for all participants in the PACU; if the score was ≥ 4, fentanyl 0.5 µg/kg was administered. Ten minutes after administration, the pain score was reassessed. If the score remained ≥ 4, an additional 0.5 µg/kg fentanyl was given, with a maximum total dose not exceeding 2 µg/kg. After returning to the ward, parents could operate the PCA pump, which was prepared with sufentanil 2 µg/kg and tropisetron 0.2 mg/kg diluted with normal saline to a total volume of 100 ml. The pump was programmed to deliver 1 ml per bolus, with a 15-minute lockout interval, up to a maximum of two boluses per hour, and a background infusion of 2 ml/h. If pain was not relieved despite reaching the maximum allowed bolus count, the research assistants were contacted to assess the patient and, if needed, administer fentanyl 0.5–1 µg/kg. The standard perioperative analgesia protocol also included a single intraoperative dose of intravenous ibuprofen (10 mg/kg). After returning to the ward, if the patient’s FLACC pain score was < 4, ibuprofen could be administered intravenously up to four times per day (maximum dose 40 mg/kg/24 h). If the FLACC score was ≥ 4, the research assistants were contacted for assessment, and fentanyl-based analgesia was provided as needed. These procedures were standardized for both groups and implemented independently of the anesthesia team to maintain blinding and ensure unbiased outcome assessment. Postoperative pain scoring method On the ward, pain scores were evaluated at 2, 4, 8, 12, and 24 h after return to the ward. Additional pain assessments were performed if the patient or their family reported discomfort between scheduled time points. For each interval, the highest pain score observed was recorded as the pain score for that period (e.g., the maximum score within the first 2 h was documented as the 2-hour pain score). Pain intensity was measured using the Face, Legs, Activity, Cry, and Consolability (FLACC) scale by trained follow-up staff who were blinded to group allocation. Pain at rest and during activity were evaluated separately. During activity assessment, the follow-up personnel encouraged the child to cough and take deep breaths to elicit pain-related behavioral responses and determine the FLACC score. When the FLACC score exceeded 4, rescue analgesia was administered according to the study protocol. Outcome measures Postoperative pain was assessed using the FLACC scale at 2, 4, 8, 12, and 24 h after surgery. The primary outcome was the pain intensity, measured by the average pain score at rest and during activity across five timepoints. This approach better reflects overall postoperative pain control during this period. Secondary outcomes included pain scores at rest and during activity within 24 h postoperatively, incidence of hypotension after intraoperative paravertebral block, total intraoperative consumption of anesthetic agents (propofol and remifentanil), and duration of surgery. During the PACU stay, the incidence of postoperative desaturation (defined as SpO₂ ≤95%) and hypoxaemia (SpO₂ <90%) was recorded. Nurse satisfaction was assessed using the Nurse Satisfaction Score (NSS; 0 = completely satisfied/easy management, 10 = complicated management). Notably, a lower Nurse Satisfaction Score represents easier postoperative management and higher nurse satisfaction [17]. The Length of PACU stay was also recorded. Postoperative outcomes included time to first rescue analgesia, total opioid consumption within 24 h (including fentanyl administered in the PACU, for postoperative rescue, and sufentanil via patient-controlled analgesia, all converted to intravenous sufentanil equivalents), and incidence of postoperative nausea and vomiting (PONV) within 24 h, graded as: 0 = none; 1 = mild nausea; 2 = severe nausea or single episode of vomiting; 3 = multiple episodes of vomiting [18]. Additional measures were time to first oral intake, time to chest tube removal, and the incidence of infection and fever during hospitalization. Postoperative pulmonary complications (pneumonia, pneumothorax, pleural effusion) were recorded. Patient satisfaction with pain treatment was assessed using the patient satisfaction with pain treatment score (0 = very dissatisfied; 4 = very satisfied). The total length of postoperative hospital stay was recorded, and all patients were followed until discharge. Statistical analysis Normality was assessed using histograms and the Kolmogorov-Smirnov test. Continuous variables with a normal distribution are presented as mean (± standard deviation [SD]), while non-normally distributed continuous variables are presented as median (interquartile range [IQR]). Categorical variables are reported as numbers (%). Quantitative data with a normal distribution were analyzed using the independent samples t-test. For non-normally distributed quantitative data, the Mann-Whitney U test was used for comparisons between groups. Categorical variables were analyzed using the chi-square test or Fisher’s exact test, as appropriate. Changes in repeatedly measured postoperative pain scores over time were analyzed using a generalized estimating equation (GEE) model. All statistical tests were two-sided, and a p-value of < 0.05 was considered statistically significant. Statistical analysis was performed using R software (version 4.1.2; R Foundation for Statistical Computing, Vienna, Austria). Sample size estimation Our sample size calculation was based on the primary outcome measured. In the preliminary study, the mean ± SD of pain intensity score was 2.2 ± 0.9 in the GA group and 1.5 ± 1.1 in the TPVB group. To achieve 90% power with a two-sided significance level (α) of 0.05, a minimum of 50 participants per group was required. To account for potential attrition and to extend the study’s scope, we planned to enroll 60 participants in each group, yielding a total sample size of 120 participants. The sample size was estimated using PASS version 15.0 (NCSS, Kaysville, UT, USA). Results Of 149 patients screened for eligibility, 29 patients were excluded: 16 patients did not meet the inclusion criteria, and 13 patients declined to participate. The remaining 120 were randomized to either the GA group or the TPVB group. Following randomization, four patients in the TPVB group and six patients in the GA group were excluded, as detailed in Fig. 2. Consequently, 56 patients in the TPVB group and 54 patients in the GA group were included in the final analysis and completed all outcome assessments. Baseline characteristics are summarized in Table 1. CONSORT participant flow chart. CONSORT indicates Consolidated Standards of Reporting Trials. TPVB Thoracic paravertebral block, GA General anesthesia Table 1Population characteristics, intraoperative variablesVariablesTPVB (n = 56)GA (n = 54)P valueAge, median [IQR], y6[5–8]6[5–8]0.571Male, number (%)33(58.9)36(66.7)0.401Height, mean (± SD), cm122(± 18)127(± 16)0.125Weight, median [IQR], kg22[17–29]25[20–31]0.052BMI, median [IQR], kg/m215.46[14.42–17.34]15.67[14.60–17.99.60.99]0.42ASA, Ⅰ/Ⅱ14/4212/420.732Anesthesia maintenancePropofol, median [IQR], mg/kg/min0.13[0.13–0.14]0.14[0.13–0.15]0.072Remifentanil, median [IQR], µg/kg/min0.19[0.16–0.23]0.33[0.28–0.36]< 0.001Surgery duration, mean (± SD), min90(± 45)96(± 51)0.485ASA American Society of Anesthesiologists, SD Standard deviation, BMI Body mass index, IQR Interquartile range, TPVB Thoracic paravertebral block, GA General anesthesia Population characteristics, intraoperative variables ASA American Society of Anesthesiologists, SD Standard deviation, BMI Body mass index, IQR Interquartile range, TPVB Thoracic paravertebral block, GA General anesthesia Primary outcome The pain intensity within 24 h during the postoperative period, the mean ± SD pain intensity score was 2.2 ± 0.3 in the GA group and 1.8 ± 0.3 in the TPVB group, representing a statistically significant difference (p < 0.001; Fig. 3). The pain intensity within 24 h during the postoperative period (***p < 0.001) Secondary outcomes Postoperative pain scores were measured at five time points. At rest, the interaction effect between time and group was statistically significant (Wald χ² = 19.86, p = 0.001), indicating that the temporal trend in pain reduction differed between groups. The main effects of time (Wald χ² = 736.49, p < 0.001) and group (Wald χ² = 40.94, p < 0.001) were also significant. Between-group comparisons showed that the TPVB group had significantly lower pain scores than the GA group at 2, 4, 8, and 12 h postoperatively (p < 0.001, p < 0.001, p < 0.001, and p = 0.01, respectively; Fig. 4A). In addition, the area under the curve (AUC) for pain scores at rest was significantly lower in the TPVB group compared with the GA group (p < 0.001; Fig. 4B). Postoperative FLACC pain scores over the initial 24 postoperative hours. A FLACC pain scores at different time points at rest. B Bar graph showing the AUC of FLACC pain scores at rest for the two groups. C FLACC pain scores at different time points during activity. D Bar graph showing the AUC of FLACC pain scores during activity for the two groups (mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001) During activity, a significant interaction between time and group was also observed (Wald χ² = 16.23, p = 0.003). The main effects of time (Wald χ² = 1425.64, p < 0.001) and group (Wald χ² = 27.27, p < 0.001) were both significant. Between-group comparisons demonstrated that pain scores at 2, 4, and 8 h postoperatively were significantly lower in the TPVB group (p < 0.001, p = 0.012, and p = 0.004, respectively; Fig. 4C). The AUC for pain scores during activity was also significantly lower in the TPVB group compared with the GA group (p = 0.001; Fig. 4D). Collectively, these findings indicate that TPVB provided more effective analgesia than GA alone, both at rest and during movement, throughout the early postoperative period. Concerning perioperative analgesic requirements, intraoperative remifentanil consumption was significantly lower in the TPVB group (p < 0.001; Table 1). The time to first postoperative rescue analgesia was significantly longer in the TPVB group (p < 0.001), and total opioid consumption in the first 24 h postoperatively was also lower in the TPVB group (p = 0.024; Table 2). Table 2Other postoperative outcomesTPVB (n = 56)GA (n = 54)P valuePACU stay, median [IQR], min21[15–27]31[25–35]< 0.001NSS score at PACU, median [IQR]0[0–2]4[2–6]< 0.001Patient satisfaction with pain treatment score, median [IQR]3[3–4]3[2–3]0.007Time to chest tube removal, median [IQR], d3[3–4]4[3–4]0.013Time of first rescue analgesia, median [IQR], h14[13–16]12[11–14]< 0.001Rescue opioid consumption, median [IQR], µg/kg0.2[0.1–0.3]0.3[0.2–0.4]0.024Time to first oral intake, median [IQR], h6[5–7]7[6–9]0.001Hospital stay, median [IQR], d5[4–6]6[5–7]< 0.001Hypotension after block, number (%)0(0)--Desaturation in the PACU, number (%)2(3.6)12(22.2)0.003Hypoxia, number (%)0(0)1(1.9)0.348Infection, number (%)4(7.1)3(5.6)0.733Fever, number (%)0(0)0(0)-Pneumothorax, number (%)9(16.1)8(14.8)0.855Pneumonia, number (%)5(8.9)12(22.2)0.054Pleural effusion, number (%)4(7.1)4(7.4)0.957PONV score, number (%)0.799050(89.3)48(88.9)15(8.9)4(7.4)21(1.8)2(3.7)30(0)0(0)TPVB Thoracic paravertebral block, GA General anesthesia, PACU Post anesthesia care unit, IQR Interquartile range, NSS Nurse Satisfaction Score (NSS; 0 = completely satisfied/easy management, 10 = complicated management), PONV Postoperative nausea and vomiting (0 = none; 1 = mild nausea; 2 = severe nausea or single episode of vomiting; 3 = multiple episodes of vomiting) Other postoperative outcomes TPVB Thoracic paravertebral block, GA General anesthesia, PACU Post anesthesia care unit, IQR Interquartile range, NSS Nurse Satisfaction Score (NSS; 0 = completely satisfied/easy management, 10 = complicated management), PONV Postoperative nausea and vomiting (0 = none; 1 = mild nausea; 2 = severe nausea or single episode of vomiting; 3 = multiple episodes of vomiting) For postoperative recovery parameters, PACU length of stay was significantly shorter in the TPVB group (p < 0.001; Table 2), as was the incidence of postoperative desaturation (p = 0.003; Table 2). Time to chest tube removal (p = 0.013) and time to first oral intake (p = 0.001) were also reduced in the TPVB group. In the TPVB group, lower nurse satisfaction scores (p < 0.001), higher patient satisfaction with pain treatment (p = 0.007), and shorter total postoperative hospital stay (p < 0.001) were observed (Table 2). There were no significant differences between groups regarding pulmonary complications or other adverse events. No incidences of post-block hypotension, local anesthetic toxicity, or block-related complications were reported in the TPVB group. Discussion In our study, TPVB significantly reduced the pain intensity during the initial 24 h postoperatively. Furthermore, TPVB was associated with decreased perioperative opioid consumption, increased patient satisfaction with postoperative pain management, and a shorter postoperative hospital stay. In pediatric patients, mediastinal tumors often cross the midline, extending beyond one side of the thoracic cavity [19]. While bilateral TPVB is commonly used for adequate analgesia in such cases, unilateral TPVB has demonstrated effective analgesia with fewer complications in thoracic surgery [20]. This study employed a single-injection technique to avoid catheter displacement issues associated with continuous TPVB. Ultrasound guidance and a two-point injection technique improved block accuracy and local anesthetic spread, ensuring more reliable analgesia. Our findings show that TPVB reduces intraoperative remifentanil use and provides adequate analgesia for up to 8 h postoperatively. Additionally, TPVB significantly lowered the pain intensity within 24 h. In our study, the incidence of desaturation during the PACU period was significantly lower in the TPVB group compared with the GA group. This improvement may be attributable to two factors. First, despite adequate lung recruitment after one-lung ventilation, insufficient analgesia can restrict respiratory movement during emergence from anesthesia. Second, higher intraoperative opioid requirements in the GA group may have resulted in residual sedative effects, thereby impairing early postoperative respiratory function. By providing effective analgesia and reducing opioid consumption, TPVB appeared to mitigate these effects and lower the risk of early respiratory depression. This finding is consistent with the principles of opioid-sparing anesthesia and may contribute to improved pulmonary recovery in children following one-lung ventilation [21, 22]. Interestingly, patients in the TPVB group demonstrated a shorter duration of chest tube insertion (mean 3 vs. 4 days). Our study primarily focused on pain outcomes within the first postoperative day. This observation may also indicate improved pulmonary function resulting from better pain control. However, no statistically significant differences were found between groups regarding pulmonary complications on chest X-rays, including pneumonia, atelectasis, or pleural effusion. While the trend favored the TPVB group, these results should be interpreted with caution. Further studies with larger sample sizes are warranted to confirm the potential respiratory benefits of TPVB in this setting. The use of TPVB offered significant benefits, including shorter PACU stays, reduced chest tube duration, and decreased postoperative hospitalization, facilitating earlier family reunification. It also minimized discomfort from prolonged chest drainage, alleviated postoperative psychological stress, and reduced financial burdens. Improved satisfaction with pain management further reflected patients’ positive overall healthcare experience. These perioperative advantages align with findings from previous studies on other regional anesthesia techniques [14, 23, 24]. In this study, we applied TPVB during thoracic mediastinal tumor resection, although its primary use has been for analgesia in cardiac procedures. However, reports on its application in pediatric cardiac surgery remain limited. A prospective study of 100 children undergoing open cardiac surgery demonstrated that TPVB effectively reduced postoperative opioid consumption and significantly lowered short-term pain scores [25]. In another study involving 180 patients undergoing cardiac surgery, TPVB provided superior analgesic efficacy and a faster recovery rate compared to intravenous analgesia alone [16]. Similarly, a retrospective review of 200 pediatric cardiac surgery patients found that TPVB shortened extubation times, reduced fentanyl requirements, delayed the need for rescue opioids, lowered short-term pain scores, and decreased ICU stays [26]. In a recent non-inferiority trial comparing the midpoint transverse process to pleura block in pediatric cardiac surgery, TPVB was used as the reference technique [27]. Mediastinal tumors, a serious condition in cardiothoracic surgery, often involve more complex pain sources, highlighting the critical role of effective postoperative pain management and recovery in these patients. The consistency of our findings with these studies further supports the efficacy of TPVB in this specific surgical setting. Although the absolute reduction in average FLACC pain scores was modest (approximately 0.4 on a 0–10 scale), its interpretation should consider both statistical and clinical perspectives. No established minimal clinically important difference (MCID) has been defined for the FLACC scale in children. However, previous studies suggest that a 1–2 point difference may represent a clinically meaningful change [28, 29]. In our study, this small numerical improvement in behavioral pain scores was accompanied by a statistically significant reduction in cumulative opioid consumption and earlier oral intake. Both outcomes are objective indicators of improved recovery. These downstream findings suggest that even moderate improvements in perioperative comfort, when associated with opioid sparing, may translate into meaningful functional recovery and shorter hospital stays—consistent with expectations for effective regional anesthesia. Ethical considerations are particularly important in pediatric pain management research. Both analgesic techniques used in this study represent accepted and commonly practiced methods for perioperative pain control. The study received approval from the institutional ethics review board and complied with the principles of the Declaration of Helsinki. In addition, all participants received multimodal analgesia and were continuously monitored for pain; any breakthrough pain was promptly treated with rescue medications. These measures ensured that no child experienced unnecessary discomfort or risk, thereby preserving both methodological rigor and ethical integrity. This study has several limitations. First, it was conducted at a single center with a limited age range of pediatric patients, which may restrict the generalizability of the findings to other institutions or broader age groups. Second, patients, guardians, and postoperative outcome assessors were blinded to group allocation. However, the anesthesiologist performing the intervention could not be blinded because a sham block procedure was not used. Nevertheless, the use of objective outcomes, such as intraoperative and postoperative opioid consumption, helps mitigate the potential for bias. Third, TPVB was administered preoperatively, and children with excessively prolonged operative times were excluded to minimize the confounding effects of drug pharmacokinetics on postoperative analgesia. Fourth, mediastinal surgery can occasionally cause bilateral chest discomfort, whereas only unilateral TPVB was performed in this study, which may have limited its analgesic coverage. Fifth, a small proportion of patients had received preoperative or neoadjuvant chemotherapy or presented with mild cachexia. These cases were evenly distributed between groups, and all surgeries were performed by the same team under standardized protocols. However, such preoperative differences could still act as potential confounders. Finally, the relatively small sample size means that the study was not powered to detect rare complications, and long-term outcomes such as chronic postsurgical pain were not assessed. The incidence of chronic pain after pediatric thoracoscopic surgery can be as high as 10–30% [30]. Future multicenter studies with larger sample sizes and extended follow‑up are warranted to confirm these findings and further clarify the broader clinical applicability of TPVB in pediatric thoracic surgery. In conclusion, incorporating ultrasound-guided unilateral two-point thoracic paravertebral block into the multimodal analgesic regimen for pediatric thoracoscopic mediastinal tumor resection significantly reduces overall pain intensity and the need for rescue analgesia within 24 h postoperatively, and shortens postoperative hospital stay without increasing complications. Acknowledgements We thank all the participants in this study. Abbreviations Thoracic paravertebral block General anesthesia Video-assisted thoracoscopic surgery Thoracic epidural anesthesia American Society of Anesthesiologists Intensive care unit Electrocardiogram Pulse oximetry Post-anesthesia care unit Patient-controlled analgesia Nurse Satisfaction Score Postoperative nausea and vomiting Standard deviation Interquartile range Area under the curve Authors’ contributions L.S. was responsible for ensuring the integrity of the data. F.W., L.J.L., and J.M.Z. contributed to the conception and design of the study and supervised the research. G.L. and H.Q.L. were responsible for subject recruitment and investigation. All authors contributed to data collection, analysis, and interpretation. The initial draft of the manuscript was prepared by L.S. All authors critically revised the manuscript for important intellectual content. Statistical analyses were performed by Z.W. and Z.Z.G. All authors reviewed and approved the final version of the manuscript. Funding No funding. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This prospective, randomized, controlled trial was conducted in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all patients and their guardians. The study was approved by the Medical Ethics Committee of Beijing Children’s Hospital, Capital Medical University ([2024]-Y-072-D). The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400083377). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.